OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis
Carla Gonçalves Schahin Saad, Matheus S.R. Silva, Perceval D. Sampaio-Barros, et al.
Joint Bone Spine (2022) Vol. 90, Iss. 1, pp. 105464-105464
Open Access | Times Cited: 12
Carla Gonçalves Schahin Saad, Matheus S.R. Silva, Perceval D. Sampaio-Barros, et al.
Joint Bone Spine (2022) Vol. 90, Iss. 1, pp. 105464-105464
Open Access | Times Cited: 12
Showing 12 citing articles:
Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis
Christopher Martin, Joshua Nazareth, Amar Jarkhi, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101926-101926
Open Access | Times Cited: 23
Christopher Martin, Joshua Nazareth, Amar Jarkhi, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101926-101926
Open Access | Times Cited: 23
Effect of DMARDs on the immunogenicity of vaccines
Yannick van Sleen, Kornelis S. M. van der Geest, Anke Huckriede, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 560-575
Closed Access | Times Cited: 18
Yannick van Sleen, Kornelis S. M. van der Geest, Anke Huckriede, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 560-575
Closed Access | Times Cited: 18
Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases
Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 274-274
Open Access | Times Cited: 4
Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 274-274
Open Access | Times Cited: 4
Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination
Ana Eliza Garcia Ralise, Taís Mendes Camargo, Fernando Augusto Lima Marson
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 9
Ana Eliza Garcia Ralise, Taís Mendes Camargo, Fernando Augusto Lima Marson
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 9
TNF inhibitors significantly attenuate the humoral immune response to COVID-19 vaccination in patients with rheumatoid arthritis
Arne Schäfer, Magdolna Szilvia Kovacs, Anna Eder, et al.
Rheumatology Advances in Practice (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 5
Arne Schäfer, Magdolna Szilvia Kovacs, Anna Eder, et al.
Rheumatology Advances in Practice (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 5
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study
Carol Hitchon, Dawn M. E. Bowdish, Gilles Boire, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1061-1061
Open Access | Times Cited: 1
Carol Hitchon, Dawn M. E. Bowdish, Gilles Boire, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1061-1061
Open Access | Times Cited: 1
The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 620-620
Open Access | Times Cited: 2
Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 620-620
Open Access | Times Cited: 2
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls
Tali Eviatar, Victoria Furer, Ari Polachek, et al.
The Journal of Rheumatology (2023) Vol. 51, Iss. 4, pp. 415-422
Closed Access | Times Cited: 2
Tali Eviatar, Victoria Furer, Ari Polachek, et al.
The Journal of Rheumatology (2023) Vol. 51, Iss. 4, pp. 415-422
Closed Access | Times Cited: 2
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study
Carol Hitchon, Dawn M. E. Bowdish, Gilles Boire, et al.
(2024)
Open Access
Carol Hitchon, Dawn M. E. Bowdish, Gilles Boire, et al.
(2024)
Open Access
Coronavirus disease 2019 vaccination in patients with rheumatic diseases: A bibliometric‐based analysis of trends
Xiufang Kong, Wei Wang
Rheumatology & autoimmunity (2024) Vol. 4, Iss. 2, pp. 81-89
Open Access
Xiufang Kong, Wei Wang
Rheumatology & autoimmunity (2024) Vol. 4, Iss. 2, pp. 81-89
Open Access
Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients – Lessons learned from the COVID-19 pandemic
Jakub Wroński, Marzena Ciechomska, Ewa Kuca-Warnawin
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115254-115254
Open Access | Times Cited: 1
Jakub Wroński, Marzena Ciechomska, Ewa Kuca-Warnawin
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115254-115254
Open Access | Times Cited: 1
SARS-CoV-2 vaccination management in patients with chronic plaque psoriasis
Francesco Bellinato, Mattia Mazzariol, Paolo Gisondi
(2022)
Closed Access
Francesco Bellinato, Mattia Mazzariol, Paolo Gisondi
(2022)
Closed Access
